fbpx

School of Business, Investing, and Finance

Learn Successful Stock Investing and Essential Concepts of Business and Entrepreneurship

Grow Your Confidence in Investing and Entrepreneurship

Here’s What Makes Gentiva Health (GTIV $5.97) an Interesting Investment Opportunity

Here is our SMC daily chart of Gentiva Health, Inc (GTIV $5.95).  We purchased shares in this company yesterday – so this is NOT an unbiased review.  We are invested in this company.  If you please click on the chart, it will open in a separate tab on your browser.  You can then zoom in and see it much more clearly.

Here are some observations about GTIV that has us invested in these shares –

  • On November 7-8, the CEO, CFO, 3 vice presidents, and 2 directors purchased a total of approx. 292,000 shares at prices ranging from $3.75 – $4.60  (worth approx. $1.2 million).  (Courtesy of Briefing.com)  (Insider buying after a disastrous 6 months for the company shares)
  • The company still makes money.  It is not a loss-making operation.
  • The company provides home health services and hospice care as well as skilled nursing and therapy services.
  • The company’s presented earnings on November 3rd that showed that for fiscal year 2011, the company will earn between $1.50-1.70/share, on revenues of $1.78-$1.82 billion.  At $6/share, the stock is selling at a price / earnings ratio of approx. 4.0.    There is room for the stock to double or triple on a low p/e of 4.  The company was able to increase revenues +18% year over year.  The stock could also simply sink back down and bump along the bottom until investors get the courage to invest in the market again.  Sentiment can change quickly, as we saw and profited from in October.
  • The shares have declined from  approx. $27/share in April down to $3.13 on October 5th.  That’s an -88% drop in the value of the shares.  At our purchase price of $5.85, the shares are down -78% from that value in April.
  • The decline in shares was precipitated by 2 things – 1. A large acquisition that the company made that brought about significant debt. 2. Uncertainty concerning the final outcome of the U.S. governments reductions in re-imbursement rates for the type of patient care that GTIV provides.
  • The government reductions in re-imbursement rates was apparently much LESS than feared.  The acquisition appears to be much better understood at the moment.
  • When you look at the vertical volume bars at the bottom of the chart, you will see many large, green columns.  These signify accumulation of the shares at these low prices.
  • The push higher in the share price on November 9th, taking the shares back above $5/share was the first STEP in what may be a new Uptrend in the shares.
  • Notice on the 3 consecutive trading days after November 5th, that the shares simply consolidated the large move from November 9th and didn’t give up much, if any ground in price.
  • Then came a downgrade to the company two days ago on November 14th.  The stock sank a bit in the morning, but recovered in the afternoon.  When a company’s shares do NOT give up ground on a downgrade, that is a good sign – particularly on such a beaten down stock.  It say’s “for the moment, there are few sellers”.  Consider this a test that the stock passed with flying colors.  So far so good.
  • Yesterday’s second step higher on high volume represents the confirmation day of the November 9th move higher.  A confirmation day, within 7 to 4 days of the first UP move is an excellent sign of investor interest and validates (for the moment) the current UPtrend that is in its early stages.
  • Notice how nice and tight the price pattern is developing in this stair stepping pattern.  This is the kind of price behavior that we really like as stock investors.
  • We have a very easy to define location to place our protective stop down at around $4.30/share.  If the shares violate the low of the November 9th move higher, we don’t want to be on board the shares.
  • It appears that the shares have been oversold due to the overall weakness in the markets, amplified by points 1 and 2 listed above.

If the rest of the market however comes unglued due to an acceleration of trouble in Europe or elsewhere, GTIV will also be faced with selling by opportunistic investors heading to the sidelines for safety.

Grow your money – on your own – inside your retirement accounts (IRA, Roth IRA… ) or in your traditional brokerage account… Follow how we apply our successful “Story-Stock Investing” process to grow our own money.  You can decide on your own whether to do the same or simply watch and learn. It takes just a few minutes a day.

Start YOUR FREE 14 Day TRIAL of Your 15Minute Market Update and Watchlist TODAY!

Only $49.95/month… Month-by-Month Subscription.  Cancel Anytime.

Click here for a glimpse of the SMC Investment Returns.

Please remember – at the Stock Market Companion we do not and cannot give individual investment advice. According to the State of Washington RCW21.20.005 the Stock Market Companion is not a Registered Financial Advisor and we do not render any advice on the basis of the specific investment situation of a particular individual. This information is for a wide readership and is not intended for any particular individual,  and under no circumstances should our Free Report, Market Update or Watchlist be considered an investment recommendation or plan for any specific individual.  By accessing this material, you agree that the Stock Market Companion will not be held liable for any actions taken by a subscriber or other parties.  Please seek the counsel of a broker or other licensed investment professional for accurate pricing and concerning the suitability of all investments that you may be considering. Disclosure : You understand that the Stock Market Companion holds positions in the above mentioned securities.  Based on market related or personal events these positions may change without notice.